Warby Parker Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 202.00K shares, a 1246.67% increase year-over-year.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 10.00K shares, a 81.80% decline year-over-year.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 7.00K shares, a 86.32% decline year-over-year.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 54.00K shares, a 88.24% decline from fiscal 2024.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 459.00K shares, a 43.25% decline from fiscal 2023.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 808.87K shares, a 28.61% increase from fiscal 2022.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 628.96K shares, a 88.31% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 202.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 219.00K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | 32.00K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 54.00K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 7.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 98.94K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 15.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 143.12K shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | 22.00K shares 10-Q · filed 2025-05-08 | 414.09K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 54.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 459.00K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 51.18K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 485.00K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 285.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 570.90K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 66.91K shares 10-Q · filed 2024-05-09 | 767.21K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 80.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 808.87K shares 10-K · filed 2024-02-29 |
| 2023-09-30 | 137.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 892.94K shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 482.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 893.03K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 108.57K shares 10-Q · filed 2023-05-09 | 539.46K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 165.01K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 628.96K shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 137.18K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 2.54M shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 128.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | |
| 2022-03-31 | 198.06K shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 2.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | 5.38M shares 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |